Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06183684 · ClinicalTrials.gov registry record · NA

Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System

A NA study of Tricuspid Regurgitation, sponsored by Laplace Interventional.

Recruiting
Registry status
NA
Development phase
45
Enrollment target
6
Study locations

NCT06183684 is a NA study of Tricuspid Regurgitation that is actively recruiting participants, run by Laplace Interventional. The registered enrollment target is 45 participants, below the 533-participant average among 17 other Tricuspid Regurgitation trials with a reported enrollment target (92% lower). The trial reports 6 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06183684, a NA study of Tricuspid Regurgitation, is actively recruiting participants, sponsored by Laplace Interventional.

RECRUITING
Registry status
NA
Development phase
45 participants
Enrollment target
6
Study locations

Study Summary

The objective of the study is to assess the safety and technical feasibility of the Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System

Conditions Studied

Tricuspid Regurgitation

Interventions

  • DEVICE Laplace TTVR System

Study Locations (6)

Arizona

  • Tucson Medical Center - Tucson

California

  • Kaiser Permanente - San Francisco

Georgia

  • Piedmont Hospital - Atlanta

Minnesota

  • Mayo Clinic - Rochester

Oregon

  • Providence Heart Institute - Portland

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 45 participants
Start Date 2024-02-19
Est. Completion 2030-12
Phase NA

Sponsor

Laplace Interventional

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06183684

The ClinicalTrials.gov registry entry for NCT06183684 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 533-participant average among 17 other Tricuspid Regurgitation trials with a reported enrollment target (92% lower). The listed sponsor is Laplace Interventional, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Tricuspid Regurgitation appearing as the primary indexed condition, and to 1 intervention - of which Laplace TTVR System is the first listed.

NCT06183684 reports 6 study locations spanning 6 distinct geographic areas - top geographies include Arizona, California, Georgia.

Frequently Asked Questions

What is clinical trial NCT06183684 about?

NCT06183684 is a clinical study titled "Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System". The objective of the study is to assess the safety and technical feasibility of the Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System

What is the current status of trial NCT06183684?

This trial is currently recruiting. It is a NA study. The enrollment target is 45 participants. The study started on 2024-02-19. Estimated completion is 2030-12.

What conditions does trial NCT06183684 study?

This clinical trial studies the following conditions: Tricuspid Regurgitation.

What interventions are being tested in trial NCT06183684?

The interventions under investigation include: Laplace TTVR System (DEVICE).

Who is sponsoring clinical trial NCT06183684?

This trial is sponsored by Laplace Interventional, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06183684 being conducted?

This trial has 6 study locations across Arizona, California, Georgia, Minnesota, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Tricuspid Regurgitation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Tricuspid Regurgitation

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.